Home  >  News
  Regeneron, Teva announce phase 3 study of fasinumab in patients with chronic pain from OA meets primary & secondary endpoints,   August 18, 2018
  Inovio begins patient dosing in phase 1/2 HIV trial of Pennvax-GP,   August 17, 2018
  ViiV Healthcare announces positive results from phase III ATLAS study of long-acting, injectable 2DR for HIV treatment,   August 16, 2018
  Rafael Pharma initiates phase I study of CPI-613 in combo with bendamustine to treat patients with relapsed/refractory T-Cell lymphoma,   August 16, 2018
  Samsung Bioepis to begin phase 1 study of SB26 UTI-Fc fusion protein to treat severe acute pancreatitis,   August 16, 2018
  Milestone Pharma begins phase 3 clinical study of etripamil for termination of PSVT episodes,   August 13, 2018
  BeiGene begins phase 3 trial of tislelizumab in combo with chemotherapy to treat advanced squamous NSCLC,   August 13, 2018
  Sobi doses first patient in phase 1/2 study of SOBI003 to treat mucopolysaccharidosis type IIIA,   August 13, 2018
  JHL Biotech gets positive CHMP scientific advice for phase III trial of proposed trastuzumab biosimilar to treat breast cancer,   August 11, 2018
  Eurocine Vaccines announces positive result from phase I/II study of Immunose FLU,   August 10, 2018
  Sangamo reports positive data from phase 1/2 trial evaluating cDNA gene therapy candidate SB-525 for Hemophilia A,   August 10, 2018
  Sanifit completes enrollment in phase 2b CaLIPSO trial to treat CVC in ESRD patients on haemodialysis,   August 09, 2018
  United Therapeutics FREEDOM-EV clinical study o Orenitram to treat patients with PAH meets primary endpoint,   August 09, 2018
  Menarini Ricerche to sponsor phase I/II study in acute myeloid leukaemia in US,   August 08, 2018
  Karolinska Institutet to participate in Immunovia's PanFAM-1 study of early detection of pancreatic cancer using blood-based test,   August 07, 2018
  Britannia Pharma phase 3 TOLEDO study shows apomorphine infusion provides effective relief of persistent motor fluctuations in PD patients,   August 07, 2018
  Mologic starts clinical trial of urine-based diagnostic for cystic fibrosis,   August 04, 2018
  CalciMedica begins phase 2a study of CM4620 to treat patients with acute pancreatitis,   August 03, 2018
  RXi Pharma reports positive results from phase 1/2 trial with RXI-109 for retinal scarring,   August 02, 2018
  Neuralstem begins phase 2 trial of neural stem cell candidate, NSI-566 to treat ischemic stroke,   August 02, 2018

cphikorea_150x60_saffron media
Copyright © 2016 Saffron Media Pvt. Ltd |